#307 Spooky Tofurkey Cakes: SGLT2 for HFpEF, Diverticulitis, VTE update, Rotator Cuff Disease
Nov 24, 2021, 08:00 AM
Fill up your plate with some spooky tofurkey cakes! Drs. Rahul Ganatra (@rbganatra) and Nora Taranto (@norataranto) help catch us up recent practice-changing articles and guidelines including EMPEROR-Reduced (SGLT2 inhibitors for HFpEF), the 2021 CHEST VTE guidelines update, whether or not antibiotics are needed for diverticulitis, and what treatments are most effective for rotator cuff disease!
Episodes | Subscribe | Spotify | Swag! | Top Picks | Mailing List | thecurbsiders@gmail.com | Free CME!
Credits
- Written by: Nora Taranto MD; Rahul Ganatra MD, MPH; Matthew Watto MD, FACP
- Show Notes: Matthew Watto MD, FACP
- Cover Art: Beth Garbitelli
- Hosts: Nora Taranto MD; Rahul Ganatra MD, MPH; Matthew Watto MD, FACP; Paul Williams MD, FACP
- Reviewer: Rahul Ganatra MD, MPH
- Executive Producer: Beth Garbitelli
- Showrunner: Matthew Watto MD, FACP
- Editor: Clair Morgan of nodderly.com
Sponsor: Birch by Helix
Birch is giving $200 off ALL mattresses and two free eco-rest pillows at BirchLiving.com/curb
Sponsor: BetterHelp
Get 10% off your first month at betterhelp.com/curb
CME Partner: VCU Health CE
The Curbsiders are partnering with VCU Health Continuing Education to offer FREE continuing education credits for physicians and other healthcare professionals. Visit curbsiders.vcuhealth.org and search for this episode to claim credit.
Show Segments
- Intro, disclaimer,
- Picks of the Week
- EMPEROR-Reduced (SGLT2 inhibitors for HFpEF)
- GRASP trial for rotator cuff disease (physiotherapy and steroid injections)
- DINAMO trial (no antibiotics for outpatients with uncomplicated diverticulitis)
- 2021 CHEST VTE Guidelines Update
- Outro